18 million churn, page-7

The distribution contract is most likely long in place.
The cream will have to be tested after production and packaging, every regulation will have to be followed to the dot as a withrawel from market is one of the worst financial burdens in biotech or health industry as a whole.

One single complain of rashes, unforeseeable side effects
etc would set this company back many months.

Diligence is the reason for this delay, Im pretty certain of it.
There is no doubt the cream is TGA approved, manufactured, we just wait for the final distribution ann.
PNO has the tendency to drop before the spike, we are almost there.